These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5463390)

  • 1. [Discrepancy between thyroid stimulation by LATS and inactivation by thyroid microsomes].
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1970 May; 46(2):122-6. PubMed ID: 5463390
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies on the properties of LATS and TSH.
    Ochi Y; Degroot LJ
    Endocrinol Jpn; 1970 Apr; 17(2):131-41. PubMed ID: 4989458
    [No Abstract]   [Full Text] [Related]  

  • 5. Discrepancy between inactivation by thyroid particulate fraction and thyroid stimulating activity of long-acting thyroid stimulator (LATS).
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1972 Jan; 34(1):7-12. PubMed ID: 5061777
    [No Abstract]   [Full Text] [Related]  

  • 6. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcellular distribution of 32 P labelled phospholipids: stimulation by thytropar and long acting thyroid stimulator.
    Satyaswaroop PG
    Experientia; 1971; 27(11):1345-6. PubMed ID: 5134311
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of mitosis in rat thyroid by long-acting thyroid stimulator.
    Garry R; Hall R
    Lancet; 1970 Apr; 1(7649):693-5. PubMed ID: 4190996
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 11. LATS inhibition by a soluble lipoprotein from human thyroid gland.
    Chopra IJ; Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of amine-containing mast cells in the mouse thyroid induced by the human long-acting thyroid stimulator (LATS).
    Melander A; Sundler F
    Endocrinology; 1973 May; 92(5):1362-6. PubMed ID: 4695424
    [No Abstract]   [Full Text] [Related]  

  • 15. On the competitive interaction of long-acting thyroid stimulator and thyrotropin in vivo.
    Burke G
    J Clin Endocrinol Metab; 1968 Feb; 28(2):286-93. PubMed ID: 5636155
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterisation of long-acting thyroid stimulator gamma-G binding protein.
    Smith BR
    Biochim Biophys Acta; 1971 Mar; 229(3):649-62. PubMed ID: 4929149
    [No Abstract]   [Full Text] [Related]  

  • 17. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of LATS, TSH and cholera toxin on the thyroid gland in nude mice.
    Ochi Y; Hachiya T; Miyazaki T; Kajita Y; Yoshimura M
    Endocrinol Jpn; 1977 Jun; 24(3):277-9. PubMed ID: 913337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.